Clungene COVID-19 Antigen Rapid Test (Saliva)

Company Profile

Hangzhou Clongene Biotech Co., Ltd. is a high-tech enterprise specialized in biological raw materials and in vitro diagnostic products.

Founded in 2004, Clongene is equipped with state-of-the-art ISO 13485:2016 accredited- China GMP compliant R&D and manufacturing facilities covering 19,000 square meters in Hangzhou, China. Our products have obtained CE certificates, FSC certificates and US FDA 510(k) Clearances.

Our products main lines:

Raw materials

• Antibodies

• Antigens

• Enzymes

Immuno diagnosis

• Colloidal gold immunoassay

• Chemiluminescence immunoassay (CLIA)

• Fluorescence immunoassay (FIA)

• Molecular diagnosis- PCR

Clongene is a leading manufacturer in technology and in vitro diagnostic products, with a solid reputation and diversified services with superior flexibility to professional distributors and partnering affiliates to the global market.

COVID-19 Antigen Rapid Test

Product Introduction

Packing Specification: 20 test/ box.

Storage Condition: Store as packaged in the sealed pouch at the temperature (4-30℃ or 40-86℉).

Period of Validity: 24 months.

Box Size: 268*124*65mm.

Box Contents

what contains in a boxbox dimention and weightwhat contains in a cartoncarton dimension and weight
20 foil pouches
20 Extraction Reagents: ampoule containing 0.3 mL of extraction reagent
20 Saliva Collectors
20 Collection tubes
20 Droppers
1 Work Station
1 Package Insert
G.W.: 0.35kg
N.W.: 0.34kg
50 boxes640X340X550mm
G.W.: 17.5kg
N.W.: 17kg

Product Features

1. Instant result at 15 minutes

2. Easy to collect samples

3. Results are clearly visible

4. No equipment required

5. Suitable for large-scale rapid screening


The COVID-19 Antigen Rapid Test (Saliva) is a lateral flow immunoassay based on the principle of double-antibody sandwich technique.

 A colored test line (T) would be visible in the result window, if SARS-CoV-2 antigens are present in the specimen. Absence of the T line suggests a negative result.


The product is a lateral flow immunoassay intended for the qualitative detection SARS-CoV-2 nucleocapsid antigens in saliva from individuals who are suspected of COVID-19 by their healthcare provider.